←Back to Expert Scholars
Translational Medicine / 转化医学HER2 Ultra-Low
Soo Chin Lee
MBBS
🏢National University Cancer Institute Singapore🌐Singapore
Head, Medical Oncology
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Soo Chin Lee leads medical oncology at NCIS and has contributed to regional HER2 ADC trials including DESTINY studies. Her translational work examines HER2 biology and treatment response in Asian patient populations. She chairs breast cancer working groups in Southeast Asia.
Share:
🧪Research Fields 研究领域
Asian breast cancer
HER2 ADCs
Pharmacogenomics
Translational trials
HER2-low biology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Soo Chin Lee 的研究动态
Follow Soo Chin Lee's research updates
留下邮箱，当我们发布与 Soo Chin Lee（National University Cancer Institute Singapore）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment